BILLERICA, Mass. -- (BUSINESS WIRE) -- RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Kathy Ordoñez to its Board of Directors.
Kathy Ordoñez brings more than 30 years of experience in the life sciences and diagnostics industries. As Senior Vice President at Quest Diagnostics, Ms. Ordonez was initially responsible for leading the company’s R&D effort and later provided oversight to multiple businesses commercializing diagnostic products and testing services. She joined Quest Diagnostics as part of its acquisition of Celera Corporation in 2011. Ms. Ordoñez was previously the Chief Executive Officer at Celera and a founder of Celera Diagnostics. Under her leadership, Celera became the leading producer of genetic testing products for HIV resistance, cystic fibrosis and high complexity tissue transplantation. Earlier in her career, Ms. Ordoñez held several senior positions at Hoffmann La-Roche, overseeing the formation of Roche Molecular Systems, where she served as President and Chief Executive Officer, and led the wide-scale commercial application of the Polymerase Chain Reaction (PCR) technology to the research, diagnostic and forensic fields.
“RainDance has achieved meaningful breakthroughs in the sensitivity and precision of genetic analysis to drive our understanding of cancer, virology, and inherited conditions. The company has multiple products in the market, an established and growing customer base, and a strong development pipeline including non-invasive Fluid Biopsy™ assays,” said Ms. Ordoñez. “I look forward to joining an experienced board and leadership team and contributing to RainDance as the company moves to its next stage of development.”
“Kathy Ordoñez is highly regarded and respected in the life science research and diagnostics industry,” said Michael Hunkapiller, Ph.D., a Board Director at RainDance Technologies. “We believe Kathy’s relationship with the team, creative mindset, and deep industry experience will help RainDance continue its success.”
Complex Genetics Made Simple
RainDance Technologies enables ground-breaking research with an innovative product portfolio to study cell-free and cell-based biomarkers for hereditary risk predisposition, initial detection, pathology and residual disease. The company’s products include:
About RainDance Technologies
RainDance Technologies is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive Fluid Biopsy™ applications that should result in more accurate, reliable, cost-effective and early detection of cancer and inherited and infectious diseases. Major research institutions and laboratories around the world rely on the RainDance systems. Based in Billerica, Massachusetts, the company supports customers using RainDrop Digital PCR and ThunderStorm Next-Generation Sequencing Content Enrichment Systems through its international sales and service operations as well as an international network of distributors and commercial service providers. For more information, please visit www.RainDanceTech.com.
The RainDrop Digital PCR System, ThunderBolts Cancer Panel, and ThunderStorm NGS Content Enrichment System are for Research Use Only; not for use in diagnostic procedures.
RainDance Technologies, the RainDance Technologies logo, ThunderBolts, RainDrop, and ThunderStorm, are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.